Q3 2016 Holdings
Filed 2016-11-14 | 50 holdings | $12.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $3.4M | 10,704 | 27.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.1M | 45,064 | 24.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.9M | 54,692 | 23.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.8M | 30,639 | 23.1% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $43.5K | 350,000 | 0.4% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $28.5K | 430,400 | 0.2% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $8.6K | 130,000 | 0.1% |
| Ishares TR(IBB) | NASDQ BIOTEC ETF | 464287556 | $7.2K | 25,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.2K | 83,700 | 0.0% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $4.1K | 85,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $4.1K | 75,686 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $3.9K | 120,000 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.8K | 81,677 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.8K | 112,300 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $3.7K | 67,953 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $3.3K | 18,400 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $3.3K | 34,626 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.1K | 18,322 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $3.0K | 176,611 | 0.0% |
| Qiagen NV(QGEN) | REG SHS | N72482107 | $3.0K | 110,565 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $3.0K | 7,512 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $3.0K | 7,188 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $3.0K | 24,571 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $2.8K | 26,859 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.8K | 32,141 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.8K | 76,439 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $2.6K | 60,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $2.4K | 45,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $1.7K | 50,000 | 0.0% |
| Medicines Co | COM | 584688105 | $1.1K | 28,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.0K | 80,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $985 | 60,000 | 0.0% |
| New SR Invt Group Inc | COM | 648691103 | $966 | 83,700 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $744 | 300,000 | 0.0% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $714 | 14,640 | 0.0% |
| Proshares TR | PSHS ULSHT SP500 | 74347B300 | $656 | 40,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $568 | 25,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $502 | 7,074 | 0.0% |
| Cepheid | COM | 15670R107 | $315 | 5,985 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $311 | 6,746 | 0.0% |
| Quintiles Transnatio Hldgs I | COM | 74876Y101 | $221 | 2,730 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $215 | 1,306 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $209 | 1,768 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $208 | 14,844 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $208 | 6,918 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $206 | 4,068 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $194 | 23,594 | 0.0% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $189 | 11,849 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $172 | 14,000 | 0.0% |
| Novavax Inc | COM | 670002104 | $54 | 25,787 | 0.0% |